ExploreWatchlistsPricing
  1. JP-listed companies
  2. KISSEI PHARMACEUTICAL CO.,LTD.
  3. Financials
  4. Accounts receivable, net

KISSEI PHARMACEUTICAL CO.,LTD. (4547)

Market cap
¥225.2B
P/E ratio
15.4x
Kissei Pharmaceutical develops and manufactures prescription drugs while also operating subsidiaries in food products, IT services, and construction.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndAccounts receivable, net (Million JPY)YoY (%)
Mar 31, 202123,058+18.48%
Mar 31, 202019,462-27.82%
Mar 31, 201926,963-6.62%
Mar 31, 201828,873+16.75%
Mar 31, 201724,730-0.95%
Mar 31, 201624,966+5.45%
Mar 31, 201523,675

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat